Get the Stockscreener App
281.45
0.84%
-2.37
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $281.45, with a volume of 3.03M.
It is down -0.84% in the last 24 hours and down -1.28% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$283.82
Open:
$286.57
24h Volume:
3.03M
Relative Volume:
1.82
Market Cap:
$74.45B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
11.92
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
-4.09%
1M Performance:
-1.28%
6M Performance:
+3.39%
1Y Performance:
-5.64%
1-Day Range:
$279.75
$289.66
1-Week Range:
$278.86
$305.44
52-Week Range:
$239.51
$315.47
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
281.45 | 75.08B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
426.09 | 384.49B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
107.47 | 135.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
373.11 | 80.86B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
400.00 | 46.40B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Cigna (CI) Stock May Trade At A Discount Despite A 33% Five Year Gain - simplywall.st
ETFs Investing in Cigna Group Stocks - TradingView
Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity? - Yahoo Finance
Cigna Group stock holds gains as higher premiums lift 2024 outlook - ad-hoc-news.de
Cigna Group stock trades steadily as medical benefits earnings and guidance frame valuation - ad-hoc-news.de
3rd Circ. Partly Revives Hospitals' ERISA Suit Against Cigna - Law360
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
UnitedHealth Rally Boosts Healthcare ETFs Despite Medicare LossesUnitedHealth Group (NYSE:UNH), State - Benzinga
What Does Representative Moskowitz's Cigna Sale Signal - Kavout | AI
(CI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Cigna Group stock holds steady as a major U.S. health insurer with diversified benefits business - ad-hoc-news.de
What CHROs need to know about health care affordability - Cigna Healthcare Newsroom
Cigna Group at TD Cowen Healthcare Conference Transcript - GuruFocus
Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's - StockStory
Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish - Stocktwits
Lawmakers Target the Power of Health Insurance Giants - The New York Times
Cigna Group (CI) Turns To AI Pharmacy Care On A Narrative That Still Looks Undervalued - simplywall.st
Daily Brief Health Care: Apnimed, Cigna Group, Exelixis Inc, Scribe Therapeutics, CSPC Pharmaceutical and more - Smartkarma
Why Cigna (CI) Stock Is Up Today - Yahoo Finance
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
Why The Cigna Group (CI) Stock Is Up Today - Quiver Quantitative
Cigna’s $30.35 EPS Floor: Can Evernorth Offset Pharmacy Margin Pressure? - Smartkarma
Josh Michelson Appointed Executive Vice President, Chief Strategy and Innovation Officer at The Cigna Group - hrtoday.in
The Cigna Group (CI) Stock Analysis: Exploring a Potential 16% Upside for Healthcare Investors - DirectorsTalk Interviews
Cigna Group stock holds steady on its business mix - ad-hoc-news.de
RBC Capital Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $337 - Moomoo
Built with America: The Cigna Group’s 230-year history of innovation in service of customers - The Cigna Group Newsroom
Cigna Group (NYSE: CI) officer Bryan Holgerson details stock, 401(k) and option positions in Form 3 - Stock Titan
Cigna Group (NYSE: CI) officer Adam Kautzner details stock and option holdings - Stock Titan
Cigna Group (NYSE: CI) officer Jason Sadler reports share and option holdings - Stock Titan
Cigna Group (CI) officer Sanford Paul A reports holding 4,073 common shares - Stock Titan
Cigna Group (NYSE: CI) officer Matthew Perlberg reports initial stock and option holdings - Stock Titan
CI Maintained by Bernstein -- Price Target Raised to $381 - GuruFocus
What to Expect From Cigna's Next Quarterly Earnings Report - Yahoo Finance
Bernstein Adjusts Price Target on Cigna Group to $381 From $371 - marketscreener.com
Bernstein raises Cigna stock price target to $381 on earnings outlook - Investing.com
CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group - StreetInsider
Independent Pharmacies Accuse Prime Therapeutics of Price-Fixing Scheme With Express Scripts - Benzinga
Did Cigna's (CI) US$100 Million AI Pharmacy Bet Just Rewire Its Specialty-Care Narrative? - simplywall.st
Hope House Accepts Cigna, Aetna & UMR for Scottsdale Rehab - The Malone Telegram
Hope House Integrates UMR, Cigna & Aetna Into Admissions - The Malone Telegram
Another Wave Of Double-Digit Obamacare Rate Hikes Coming For 2027 - Forbes
Cigna Group focuses on health benefits growth as investors watch the US managed-care sector - Ad-hoc-news.de
The Cigna Group Foundation Launches 2026 Grant Program to Support Veterans - AOL.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges - Investing.com
Cigna’s SWOT analysis: stock navigates PBM transition challenges By Investing.com - Investing.com Canada
Cigna Group stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Specialty Pharmacy Gets Even Hotter After Cigna Investment And Peak Rock’s Asembia Buy - Forbes
The Cigna Group's Second Quarter 2026 Earnings Release Details - Caledonian Record
The Cigna Group sets July 30 earnings call, webcast and replay - Stock Titan
Cigna Group focuses on health benefits and steady operations - ad-hoc-news.de
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cigna Group Stock (CI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kates Jamie G | Chief Accounting Officer |
Jun 12 '26 |
Sale |
298.61 |
899 |
268,452 |
2,368 |
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):